Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000903423-15-000540
Filing Date
2015-09-02
Accepted
2015-09-02 12:43:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 glaxotheravance-13g_0902.htm SC 13G 29183
  Complete submission text file 0000903423-15-000540.txt   30747
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Filed by) CIK: 0001131399 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88552 | Film No.: 151089008
SIC: 2834 Pharmaceutical Preparations